Opulen Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$322K Buy
278
+19
+7% +$22.4K 0.2% 87
2026
Q2
$311K Buy
259
+36
+16% +$36.8K 0.2% 87
2026
Q1
$205K Buy
223
+14
+7% +$14.2K 0.14% 114
2025
Q4
$225K Buy
+209
New +$200K 0.16% 98

Other funds holding LLY

Opulen Financial Group's LLY Position: Q3 2026 in Review

Opulen Financial Group increased its Eli Lilly (LLY) stake by 7.3% in Q3 2026, buying an estimated $22.4K and bringing the position to 278 shares worth $322K. The position accounts for 0.2% of the portfolio, ranked #87.

Opulen Financial Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Opulen Financial Group held 278 shares of Eli Lilly worth $322K as of Q3 2026.
  • Opulen Financial Group bought 19 Eli Lilly shares in Q3 2026, an estimated $22.4K.
  • Eli Lilly made up 0.2% of Opulen Financial Group's portfolio in Q3 2026, its #87 holding.
  • Opulen Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Opulen Financial Group's 13F filing for Q3 2026, filed 22 Oct 2026.